INTERACTIVE EFFECTS OF BILE SALT AND LIPOLYTIC ENZYMES IN CHOLESTEROL ABSORPTION

胆盐和脂肪分解酶对胆固醇吸收的相互作用

• 批准号: 6301196
• 负责人: David Yiu-Kwan Hui
• 金额: $ 16.43万
• 依托单位: UNIVERSITY OF CINCINNATI
• 依托单位国家: 美国
• 财政年份: 2000
• 资助国家: 美国
• 起止时间: 2000-03-01 至 2001-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6301196
• 关键词: Adenoviridae; biliary tract; cholestane compound; cholesterol; clinical research; cystic fibrosis; dietary supplements; enzyme activity; epithelium; gastrointestinal nutrient absorption; gene deletion mutation; gene therapy; genetically modified animals; human subject; intermolecular interaction; laboratory mouse; lipase; lipid transport; lipolysis; nonhuman therapy evaluation; nutrition related tag; pancreas disorder; pancreas enzyme; phospholipase A2; recombinant virus; transfection

This project focuses on the relationship between luminal lipid digestion and cholesterol absorption, with particular attention paid to the role of pancreatic phospholipase A/2 (PLA2) and pancreatic lipase (PL) in this process. The specific hypothesis is that cholesterol absorption efficiency is correlated to the efficiency of luminal lipid digestion, which in turn is dictated by the amount and type of bile acid and the activity of lipolytic enzymes present in the intestinal lumen. We postulate that: (1) bile acids and lipolytic enzymes interact in the re- modeling of luminal lipids prior to their absorption by the enterocytes; (2) variations in the level of pancreatic lipolytic enzyme expression contribute to individual differences in cholesterol absorption efficiency; and (3) ectopic expression of pancreatic lipolytic enzymes in the biliary epithelium is a feasible treatment for fat malabsorption associated with pancreatic insufficiency and cystic fibrosis. Four specific aims are proposed to address these hypotheses: Specific Aim 1 will determine the effect of bile acid composition on luminal lipolysis. Experiments will be performed in vitro to determine the effects of bile acid composition on (i) PLA2 and PL activities, (ii) cholesterol distribution among lipid emulsions, phospholipid vesicles, and mixed micelles, and (iii) cholesterol uptake by intestinal cells in culture and mucosal sheets. The in vitro observations will be correlated with in vivo affects of bile acid supplementation on luminal lipolytic enzyme activities, cholesterol solubilization, and cholesterol absorption efficiency in human subjects. Specific Aim 2 will produce PLA2 knockout mice to test eh importance of PLA2 in cholesterol absorption. Specific Aim 3 will produce PL knockout mice to test the impact of PL gene deletion on fat and cholesterol absorption. The PL knockout mice produced in this study will be used in Specific Aim 4 to determine if recombinant adenovirus mediated PL gene transfer to the biliary epithelium can restore fat absorption in the absence of pancreatic lipase expression by the pancreas. These studies will provide nutritionists and clinicians with mechanistic information to design effective dietary and/or therapeutic treatment for diseases due to diet- induced hyperlipidemia or to aberrant fat digestion and transport due to pancreatic diseases.

本项目主要研究鲁米那脂质消化与 和胆固醇的吸收，特别注意的作用， 胰磷脂酶A/2（PLA 2）和胰脂肪酶（PL）在 这个过程具体的假设是胆固醇的吸收 效率与鲁米那脂质消化的效率相关， 这又取决于胆汁酸的量和类型， 存在于肠腔中的脂解酶的活性。我们 假设：（1）胆汁酸和脂解酶在重组中相互作用， 在肠上皮细胞吸收前对管腔脂质进行建模; (2)胰腺脂解酶表达水平的变化 导致胆固醇吸收的个体差异 效率;和（3）胰腺脂解酶的异位表达 是治疗脂肪吸收不良的可行方法 与胰腺功能不全和囊性纤维化有关。四 针对这些假设提出了具体目标：具体目标1 将确定胆汁酸组成对管腔脂解的影响。 将在体外进行实验，以确定胆汁 酸组成对（i）PLA 2和PL活性，（ii）胆固醇 脂肪乳剂、磷脂囊泡和混合囊泡中的分布 胶束，和（iii）培养物中肠细胞的胆固醇摄取 和粘膜片。体外观察结果将与体内 补充胆汁酸对管腔脂肪分解酶的体内影响 活性、胆固醇溶解和胆固醇吸收 在人类实验中的效率。特定目标2将产生PLA 2敲除 小鼠来测试PLA 2在胆固醇吸收中的重要性。具体 目的3将产生PL基因敲除小鼠以测试PL基因的影响 对脂肪和胆固醇吸收的影响。PL基因敲除小鼠 本研究中产生的结果将用于具体目标4，以确定 重组腺病毒介导的PL基因胆道转移 上皮细胞可以恢复脂肪吸收的情况下，胰腺 胰腺脂肪酶的表达。这些研究将提供 营养学家和临床医生， 有效的饮食和/或治疗性治疗， 诱发的高脂血症或异常的脂肪消化和运输， 胰腺疾病